Enzo Life Sciences: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Enzo Life Sciences
Largest movements
- Receivables within one year -€341,428
down €341,428 (-75.2%), from €454,066 to €112,638
of which Trade receivables: -€341,596
- Cash -€19,385
down €19,385 (-39.2%), from €49,440 to €30,055
mainly Debts after one year (-€209,739) and Net result for the year (-€185,783)
- Debts after one year -€209,739
down €209,739 (-16.3%), from €1.3m to €1.1m
- Profit (loss) carried forward -€185,783
down €185,783 (-20.7%), from -€897,147 to -€1.1m
- Trade debts +€42,455
up €42,455 (+136%), from €31,125 to €73,580
- Tax, wage and social debts -€7,508
down €7,508 (-22.2%), from €33,805 to €26,297
of which Remuneration and social security: -€4,598
- Turnover -€1.4m
down €1.4m (-62.6%), from €2.2m to €814,945
- Goods and materials -€930,562
down €930,562 (-60.4%), from €1.5m to €611,374
- Services and other goods -€379,034
down €379,034 (-59.9%), from €632,798 to €253,764
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €503,506 | €142,693 | -€360,813 | -71.7% |
| Current assets | 29/58 | €503,506 | €142,693 | -€360,813 | -71.7% |
| Amounts receivable within one year | 40/41 | €454,066 | €112,638 | -€341,428 | -75.2% |
| Trade receivables | 40 | €453,930 | €112,334 | -€341,596 | -75.3% |
| Other amounts receivable | 41 | €136 | €304 | +€168 | +124% |
| Cash at bank and in hand | 54/58 | €49,440 | €30,055 | -€19,385 | -39.2% |
| Total equity and liabilities | 10/49 | €503,506 | €142,693 | -€360,813 | -71.7% |
| Equity | 10/15 | -€845,373 | -€1,031,156 | -€185,783 | -22.0% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €33,182 | €33,182 | = | 0.0% |
| Distributable reserves | 133 | €33,182 | €33,182 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€897,147 | -€1,082,930 | -€185,783 | -20.7% |
| Amounts payable | 17/49 | €1,348,879 | €1,173,849 | -€175,030 | -13.0% |
| Amounts payable after more than one year | 17 | €1,283,711 | €1,073,972 | -€209,739 | -16.3% |
| Other amounts payable | 178/9 | €1,283,711 | €1,073,972 | -€209,739 | -16.3% |
| Amounts payable within one year | 42/48 | €65,168 | €99,877 | +€34,709 | +53.3% |
| Trade debts | 44 | €31,125 | €73,580 | +€42,455 | +136% |
| Suppliers | 440/4 | €31,125 | €73,580 | +€42,455 | +136% |
| Taxes, remuneration and social security | 45 | €33,805 | €26,297 | -€7,508 | -22.2% |
| Taxes | 450/3 | €11,803 | €8,893 | -€2,910 | -24.7% |
| Remuneration and social security | 454/9 | €22,002 | €17,404 | -€4,598 | -20.9% |
| Other amounts payable | 47/48 | €238 | - | -€238 | |
| Operating income | 70/76A | €2,180,284 | €814,947 | -€1.4m | -62.6% |
| Turnover | 70 | €2,180,284 | €814,945 | -€1.4m | -62.6% |
| Other operating income | 74 | - | €2 | +€2 | |
| Operating charges | 60/66A | €2,313,340 | €997,466 | -€1.3m | -56.9% |
| Goods for resale, raw materials and consumables | 60 | €1,541,936 | €611,374 | -€930,562 | -60.4% |
| Purchases | 600/8 | €1,541,936 | €611,374 | -€930,562 | -60.4% |
| Services and other goods | 61 | €632,798 | €253,764 | -€379,034 | -59.9% |
| Remuneration, social security and pensions | 62 | €130,981 | €131,031 | +€50 | 0.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €7,085 | €827 | -€6,257 | -88.3% |
| Other operating charges | 640/8 | €541 | €470 | -€71 | -13.2% |
| Operating profit (loss) | 9901 | -€133,057 | -€182,519 | -€49,462 | -37.2% |
| Financial charges | 65/66B | €3,188 | €3,264 | +€76 | +2.4% |
| Recurring financial charges | 65 | €3,188 | €3,264 | +€76 | +2.4% |
| Other financial charges | 652/9 | €3,188 | €3,264 | +€76 | +2.4% |
| Profit (loss) for the period before taxes | 9903 | -€136,245 | -€185,783 | -€49,538 | -36.4% |
| Profit (loss) for the period | 9904 | -€136,245 | -€185,783 | -€49,538 | -36.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€136,245 | -€185,783 | -€49,538 | -36.4% |
Source: filed annual accounts (NBB), financial years ended 31 July 2024 and 31 July 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.